Literature DB >> 15286229

Terminal 22q deletion syndrome: a newly recognized cause of speech and language disability in the autism spectrum.

Melanie A Manning1, Suzanne B Cassidy, Carol Clericuzio, Athena M Cherry, Stuart Schwartz, Louanne Hudgins, Gregory M Enns, H Eugene Hoyme.   

Abstract

OBJECTIVE: Cryptic subtelomeric chromosome rearrangements account for 6% to 10% of idiopathic mental retardation. As cytogenetic and molecular techniques have become more sophisticated, the number of genetic syndromes attributed to these microdeletions has increased. To date, 64 patients have been described in the literature with a more recently recognized microdeletion syndrome, del 22q13.3. The purpose of this study is to present 11 new cases of this recently described syndrome to delineate further the phenotype and to alert the clinician to another genetic condition that should be considered in the differential diagnosis of early hypotonia, delayed speech acquisition, and autistic behavior.
METHODS: Eleven patients were evaluated in 3 academic institutions. Clinical features and results of cytogenetic testing were recorded and tabulated. Reasons for referral for genetic evaluation included developmental delay, severe expressive speech and language delay, and dysmorphic features.
RESULTS: Age of presentation ranged from 5 months to 46 years. There were 10 female patients and 1 male patient. All of the patients exhibited delayed motor development, some degree of hypotonia, and severe expressive speech and language delay. Dysmorphic facial features included epicanthal folds, large cupped ears, underdeveloped philtrum, loss of cupid's bow, and full supraorbital ridges. Six patients exhibited autistic-like behaviors. Microscopically visible chromosome deletions were observed in 6 patients. In the remainder, the deletion was detected with the use of fluorescence in situ hybridization.
CONCLUSIONS: Hypotonia and developmental delay are nonspecific findings observed in many malformation and genetic syndromes. However, in association with severe speech and language delay and autistic-like behavior, this phenotype may be a significant indication to consider the 22q13 deletion syndrome as a potential cause.

Entities:  

Mesh:

Year:  2004        PMID: 15286229     DOI: 10.1542/peds.114.2.451

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  41 in total

1.  Systematic screening for subtelomeric anomalies in a clinical sample of autism.

Authors:  Thomas H Wassink; Molly Losh; Joseph Piven; Val C Sheffield; Elizabeth Ashley; Erik R Westin; Shivanand R Patil
Journal:  J Autism Dev Disord       Date:  2007-04

Review 2.  Autism spectrum disorder and epilepsy: Disorders with a shared biology.

Authors:  Bo Hoon Lee; Tristram Smith; Alex R Paciorkowski
Journal:  Epilepsy Behav       Date:  2015-04-19       Impact factor: 2.937

3.  Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders.

Authors:  Christelle M Durand; Catalina Betancur; Tobias M Boeckers; Juergen Bockmann; Pauline Chaste; Fabien Fauchereau; Gudrun Nygren; Maria Rastam; I Carina Gillberg; Henrik Anckarsäter; Eili Sponheim; Hany Goubran-Botros; Richard Delorme; Nadia Chabane; Marie-Christine Mouren-Simeoni; Philippe de Mas; Eric Bieth; Bernadette Rogé; Delphine Héron; Lydie Burglen; Christopher Gillberg; Marion Leboyer; Thomas Bourgeron
Journal:  Nat Genet       Date:  2006-12-17       Impact factor: 38.330

4.  Linkage analysis in a Dutch population isolate shows no major gene for left-handedness or atypical language lateralization.

Authors:  Metten Somers; Roel A Ophoff; Maartje F Aukes; Rita M Cantor; Marco P Boks; Meenakshi Dauwan; Kees L de Visser; René S Kahn; Iris E Sommer
Journal:  J Neurosci       Date:  2015-06-10       Impact factor: 6.167

5.  Deep Phenotyping of Development, Communication and Behaviour in Phelan-McDermid Syndrome.

Authors:  Gilles Droogmans; Ann Swillen; Griet Van Buggenhout
Journal:  Mol Syndromol       Date:  2019-11-05

Review 6.  Phelan-McDermid Syndrome and SHANK3: Implications for Treatment.

Authors:  Jesse L Costales; Alexander Kolevzon
Journal:  Neurotherapeutics       Date:  2015-07       Impact factor: 7.620

7.  The role of rare structural variants in the genetics of autism spectrum disorders.

Authors:  M Kusenda; J Sebat
Journal:  Cytogenet Genome Res       Date:  2009-03-11       Impact factor: 1.636

Review 8.  Syndromic autism: causes and pathogenetic pathways.

Authors:  Arianna Benvenuto; Romina Moavero; Riccardo Alessandrelli; Barbara Manzi; Paolo Curatolo
Journal:  World J Pediatr       Date:  2009-08-20       Impact factor: 2.764

9.  Recent advances in the pathogenesis of syndromic autisms.

Authors:  A Benvenuto; B Manzi; R Alessandrelli; C Galasso; P Curatolo
Journal:  Int J Pediatr       Date:  2009-06-21

10.  Copy number variation and association analysis of SHANK3 as a candidate gene for autism in the IMGSAC collection.

Authors:  Nuala H Sykes; Claudio Toma; Natalie Wilson; Emanuela V Volpi; Inês Sousa; Alistair T Pagnamenta; Raffaella Tancredi; Agatino Battaglia; Elena Maestrini; Anthony J Bailey; Anthony P Monaco
Journal:  Eur J Hum Genet       Date:  2009-04-22       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.